Studies have reported that mTOR inhibitors achieve an increasing anti-tumor effect when combined with other drugs such as anti-osteoporotic drugs, extra-terminal domain protein inhibitors, and conventional ChT drugs [39]. Here, MTOR is linked to neoplasm.